• 3
    Haplo
    Score
  • 0
    Triplo
    Score

Gene Facts External Data Attribution

HGNC Symbol
CLCN5 (HGNC:2023) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
HGNC Name
chloride voltage-gated channel 5
Gene type
protein-coding gene
Locus type
gene with protein product
Previous symbols
NPHL2, NPHL1
Alias symbols
DENTS, XLRH, hClC-K2, hCIC-K2, CLC5, XRN, ClC-5
%HI
13.07(Read more about the DECIPHER Haploinsufficiency Index)
pLI
0.99(Read more about gnomAD pLI score)
LOEUF
0.28(Read more about gnomAD LOEUF score)
Cytoband
Xp11.23
Genomic Coordinates
GRCh37/hg19: chrX:49687206-49863887 NCBI Ensembl UCSC
GRCh38/hg38: chrX:49922596-50099230 NCBI Ensembl UCSC
MANE Select Transcript
NM_001127898.4 ENST00000376091.8 (Read more about MANE Select)
Function
Proton-coupled chloride transporter. Functions as antiport system and exchanges chloride ions against protons (PubMed:20466723). Important for normal acidification of the endosome lumen. May play an important role in renal tubular function. The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons. The absence of conserved gating glutamate residues is typical for family members that function as channels (Proba... (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

Dosage ID:
ISCA-22682
ClinGen Curation ID:
CCID:006875
Curation Status:
Complete
Issue Type:
Dosage Curation - Gene
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency (3)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Last Evaluated:
10/18/2012

Haploinsufficiency (HI) Score Details

HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency (Disclaimer)
HI Disease:
HI Evidence:
  • PUBMED: 15086899
    32 unrelated males with a clinical diagnosis of Dent's disease underwent sequencing of CLCN5. Sixteen mutations were found in 19/32 individuals with 10 missense, 4 nonsense, and 2 frameshift mutations described.
  • PUBMED: 22083641
    In this review by Lourdel et al. (2012), 148 previously reported mutations in CLCN5 associated with Dent's disease were summarized. Of the 148 mutations reported, 36% were nonsense mutations, 30% missense mutations, 18% deletion mutations, 7% splice site mutations, and 6% insertional mutations. These mutations are divided into 3 categories depending on their effect on protein function. Functional studies and animal models are also summarized.
HI Evidence Comments:
Mutations in CLCN5 account for approximately 60% of Dent's disease, a proximal renal tubular dysfunction, which is characterized by low molecular weight (LMW) proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, and chronic kidney disease (CKD).
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Genomic View

Select assembly: (NC_000023.10) (NC_000023.11)